» Articles » PMID: 17852435

Predictive Factors of Septic Shock and Mortality in Neutropenic Patients

Overview
Journal Hematology
Specialty Hematology
Date 2007 Sep 14
PMID 17852435
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Neutropenia is a major risk factor for developing a serious infection. Bacteremia still causes significant mortality among neutropenic patients with cancer. The purpose of this study was to identify risk factors for septic shock and for mortality in neutropenic patients with leukemia and bacteremia. Consecutive samples from 20 patients with acute myeloid leukemia and bacteremia were studied during a 1 year period (January-December 2003). All patients received empirical antibiotic therapies for febrile episodes using ceftazidime plus amikacin. About 110 neutropenic febrile episodes were noted: clinically documented 14.54%, microbiologically documented 16.36% and fever of unknown origin 69.09%. Gram-negative organism caused eight febrile episodes: Pseudomonas (5), Klebsiella (3). Gram-positive organism caused 10 episodes: Staphylococcus (6), Streptococci (2), Enterococci (2). Pulmonary infection accounted for 25% of clinically documented infections. About 14 of the 110 febrile episodes were associated with septic shock causing mortality in 7 patients. In a univariate analysis variables associated with septic shock were: pulmonary infection (OR = 17, p = 0.001), serum bicarbonate < 17 mmol/l (OR = 68, p < 0.001) and serum lactate >3 mmol/l (OR = 62, p < 0.001). Variables associated with mortality were: pulmonary infection (OR = 83, p < 0.001) and serum bicarbonate < 17 mmol/l (OR = 61, p < 0.001). In a multivariate analysis two variables were associated with septic shock: pulmonary infection (OR = 5, p = 0.043) and serum lactate >3 mmol/l (OR = 10, p = 0.003). An elevated serum lactate (>3 mmol/l) and low serum bicarbonate ( < 17 mmol/l) at the onset of bacteremia are useful biomarkers in predicting septic shock and mortality in neutropenic patients.

Citing Articles

Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever.

Slatnick L, Miller K, Scott H, Loi M, Esbenshade A, Franklin A Front Oncol. 2022; 12:990279.

PMID: 36276165 PMC: 9583361. DOI: 10.3389/fonc.2022.990279.


Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy.

Cennamo F, Masetti R, Largo P, Argentiero A, Pession A, Esposito S Children (Basel). 2021; 8(12).

PMID: 34943282 PMC: 8700030. DOI: 10.3390/children8121086.


[Neutropenic Fever in Lung Cancer: Clinical Aspects Related to Mortality and Antibiotic Failure].

Rodrigues I, Nascimento L, Pimenta A, Raimundo S, Conde B, Fernandes A Zhongguo Fei Ai Za Zhi. 2021; 24(11):764-769.

PMID: 34802207 PMC: 8607283. DOI: 10.3779/j.issn.1009-3419.2021.102.36.


Serum Lactate: A Predictor of Septic Shock in Childhood Cancers with Febrile Neutropenia.

Suwanpakdee D, Prasertsin W, Traivaree C, Rujkijyanont P Glob Pediatr Health. 2021; 8:2333794X211022711.

PMID: 34104707 PMC: 8170332. DOI: 10.1177/2333794X211022711.


Clinical factors predictive of mortality in acute leukemia patients with febrile neutropenia.

Wanitpongpun C, Teawtrakul N, Lanamtieng T, Chansung K, Sirijeerachai C, Amampai W Am J Blood Res. 2021; 11(1):59-65.

PMID: 33796390 PMC: 8010598.